Category Archives: Pr Newswire

SAN JOSE, Calif., July 30, 2024 /PRNewswire/ — DapuStor Corporation, a pioneer in high-performance data storage solutions, announced today that it is expanding its collaboration with Marvell to deliver breakthrough Flexible Data Placement (FDP) technology optimized for Quad-Level Cell (QLC) and Triple-Level Cell (TLC) Solid-State Drives (SSDs). This collaboration aims to revolutionize the storage industry […]

ONTARIO, Calif., July 30, 2024 /PRNewswire/ — Nature’s Miracle Holding Inc. (NASDAQ: NMHI) (“Nature’s Miracle” or the “Company”), today closed its previously announced underwritten public offering of 5,000,000 shares of common stock, par value $0.0001 per share, at a public offering price of $0.24 per share, for aggregate gross proceeds of $1.2 million prior to deducting underwriting […]

XEMBIFY is the first and only 20% subcutaneous immunoglobulin (SCIg) with FDA-approved dosing for treatment-naïve patients, enabling them to go straight to SCIg without initial intravenous therapy Approval, which also includes biweekly dosing, follows phase 4 study data demonstrating comparable total Ig levels when administering XEMBIFY every two weeks versus weekly The expanded label for […]

Windsong Radiology to Champion First Wave of ProFound AI Breast Health Suite Expansion NASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced a strategic agreement with Windsong Radiology Group, one of US Radiology Specialists, […]

BOSTON, July 29, 2024 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, and members of management will participate in one-on-one meetings at the BTIG Virtual Biotechnology Conference being held […]

Research Published in THE LANCET’s eClinicalMedicineEscharEx® Outperforms Non-Surgical Standard of Care in Debridement and Promotion of Healthy Granulation Tissue YAVNE, Israel, July 29, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announces the peer-reviewed publication on the Phase II ChronEx study assessing the safety […]

– Co-primary endpoint of PASI 75 and sPGA 0/1 score at 24 weeks to serve as basis for U.S. regulatory submission – – Pivotal Phase 3 program supported by positive Phase 2 STRIDE clinical data as well as ongoing open-label extension (OLE) study – – Topline data anticipated in 2026 – SOUTH SAN FRANCISCO, Calif., […]

THE HOTEL HIGASHIYAMA KYOTO TOKYU, A Pan Pacific Hotel, will be added to group’s portfolio in Japan from 10 January 2025 SINGAPORE, July 29, 2024 /PRNewswire/ — Pan Pacific Hotels Group debuts in Kyoto with the signing of a strategic partnership with Tokyu Hotels following the launch of BELLUSTAR TOKYO, A Pan Pacific Hotel and HOTEL […]

GUANGZHOU, China, July 29, 2024 /PRNewswire/ — Xuan Wu Cloud Technology Holdings Limited (“Xuan Wu Cloud” or the “Group,” stock code: 2392.HK), a leading intelligent CRM service provider in China, today announced its positive alert for the six months ended June 30, 2024. Based on the information currently available to the Board and a preliminary […]

Revenue Reached RMB9,259 Million in the Second Quarter, Excluding COVID-19 Commercial Projects, Up 0.3% Year-over-Year Revenue Reached RMB17,241 Million for the First Half, Excluding COVID-19 Commercial Projects, Down 0.7% Year-over-Year Net Profit Attributable to the Owners of the Company Reached RMB4,240 Million, and Diluted Earnings per Share (EPS) of RMB1.45 for the First Half  Adjusted Non-IFRS […]